Name: Sucampo Pharmaceuticals (SCMP) Stock
Brand: Sucampo Pharmaceuticals
Rating: 5.5 (3 reviews)

SCMP Latest News, Press Relases and Analysis

All

Press Releases

8 years ago - By: Analyst Ratings

B.Riley FBR Sticks to Its Hold Rating for Sucampo Pharmaceuticals

8 years ago - By: S&P Dow Jones Indices - Mentions: JRVR BYD CAA CUDA ...

Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600

8 years ago - By: Benzinga - Mentions: PX MNK

Barclays: Mallinckrodt's Sucampo Deal Overshadowed By Competitive Threats

8 years ago - By: TalkMarkets - Mentions: MNK

Mallinckrodt: Is The Generics Sale In Trouble?

8 years ago - By: Benzinga - Mentions: WSC BBBY EXPO GILD ...

Benzinga's Top Upgrades, Downgrades For January 26, 2018

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

8 years ago - By: Monteverde & Associates PC

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Sucampo Pharmaceuticals, Inc. In The District Of Maryland

8 years ago - By: Andrews & Springer LLC

SUCAMPO PHARMACEUTICALS (SCMP) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating Sucampo Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty

8 years ago - By: Lifshitz & Miller Law Firm - Mentions: AMD FMCI ZAIS GPRO ...

Lifshitz & Miller LLP Announces Investigation of Advanced Micro Devices, Aflac Incorporated, DST Systems, Inc., Forum Merger Corporation, GoPro, Inc., Sucampo Pharmaceuticals, Inc. and ZAIS Group Holdings, Inc.

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): PT Raised News

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

8 years ago - By: Levi & Korsinsky, LLP

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): PT Raised News

8 years ago - By: Wolf Popper LLP - Mentions: MNK

Wolf Popper LLP Investigates the Proposed Acquisition of Sucampo Pharmaceuticals, Inc. by Mallinckrodt plc

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

8 years ago - By: TalkMarkets - Mentions: MNK

A Moody's Downgrade Could Punish Mallinckrodt

8 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Sucampo Pharmaceuticals, Inc. -- SCMP

8 years ago - By: The Briscoe Law Firm, PLLC

SUCAMPO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc

8 years ago - By: Levi & Korsinsky, LLP

CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

8 years ago - By: Levi & Korsinsky, LLP

Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

8 years ago - By: TalkMarkets - Mentions: MNK RDY CELG GILD

Mallinckrodt: Impact Of $1.2 Billion Sucampo Deal Could Be Ethereal

8 years ago - By: Rigrodsky & Long, P.A.

SUCAMPO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

8 years ago - By: TalkMarkets - Mentions: MNK

Sucampo 'Substantially' Undervalued In $18 Per Share Deal, Says Nomura Instinet

8 years ago - By: MarketWatch - Mentions: DJIA SPX XLE COMP ...

Dow ends lower as slide in Apple offsets gains in retail, energy stocks

8 years ago - By: StockNews.com

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

8 years ago - By: MarketWatch - Mentions: DJIA SPX COMP M ...

Dow industrials face selling pressure as Apple’s stock stumbles

8 years ago - By: TalkMarkets - Mentions: MNK

Sucampo Pharmaceuticals, Inc. Stock Climbs On Mallinckrodt PLC Buyout Deal

8 years ago - By: MarketWatch - Mentions: DJIA SPX COMP M ...

Dow fights to retain grip higher as Apple’s stock stumbles

8 years ago - By: MarketWatch - Mentions: DJIA SPX COMP AAPL ...

U.S. stock market under pressure as Apple’s share stumbles in postholiday trade

8 years ago - By: MarketWatch - Mentions: YMH8 ESH8 NQH8 DJIA ...

Sucampo Pharmaceuticals (SCMP) Stock News

SCMP Latest News, Press Relases and Analysis

B.Riley FBR Sticks to Its Hold Rating for Sucampo Pharmaceuticals

Boyd Gaming Set to Join S&P MidCap 400; Ring Energy, James River Group Holdings and EVERTEC to Join S&P SmallCap 600

Barclays: Mallinckrodt's Sucampo Deal Overshadowed By Competitive Threats

Mallinckrodt: Is The Generics Sale In Trouble?

Benzinga's Top Upgrades, Downgrades For January 26, 2018

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

Monteverde & Associates PC Files Class Action Lawsuit On Behalf Of Shareholders Of Sucampo Pharmaceuticals, Inc. In The District Of Maryland

SUCAMPO PHARMACEUTICALS (SCMP) SHAREHOLDER ALERT – Andrews & Springer LLC Is Investigating Sucampo Pharmaceuticals, Inc. for Potential Breaches of Fiduciary Duty

Lifshitz & Miller LLP Announces Investigation of Advanced Micro Devices, Aflac Incorporated, DST Systems, Inc., Forum Merger Corporation, GoPro, Inc., Sucampo Pharmaceuticals, Inc. and ZAIS Group Holdings, Inc.

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): PT Raised News

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): PT Raised News

Wolf Popper LLP Investigates the Proposed Acquisition of Sucampo Pharmaceuticals, Inc. by Mallinckrodt plc

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

A Moody's Downgrade Could Punish Mallinckrodt

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Sucampo Pharmaceuticals, Inc. -- SCMP

SUCAMPO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Investigates Sale to Mallinckrodt plc

CORRECTING and REPLACING Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

Investor Alert: Levi & Korsinsky, LLP Notifies Investors of an Investigation Concerning Whether the Sale of Sucampo Pharmaceuticals, Inc. to Mallinckrodt plc is Fair to Shareholders

Mallinckrodt: Impact Of $1.2 Billion Sucampo Deal Could Be Ethereal

SUCAMPO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Buyout

Sucampo 'Substantially' Undervalued In $18 Per Share Deal, Says Nomura Instinet

Dow ends lower as slide in Apple offsets gains in retail, energy stocks

Sucampo Pharmaceuticals, Inc. - Class A Common Stock (SCMP): Downgrade News

Dow industrials face selling pressure as Apple’s stock stumbles

Sucampo Pharmaceuticals, Inc. Stock Climbs On Mallinckrodt PLC Buyout Deal

Dow fights to retain grip higher as Apple’s stock stumbles

U.S. stock market under pressure as Apple’s share stumbles in postholiday trade

Dow, tech sector set to slip as Apple’s stock stumbles in postholiday trade